These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10452288)

  • 1. Reply to the letter from G. Smith. Angiotensin converting enzyme inhibitor (ACEI) and reflux nephropathy.
    Lama G; Salsano ME; Pedullà M; Grassia C; Ruocco G
    Pediatr Nephrol; 1999 Aug; 13(6):552. PubMed ID: 10452288
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up.
    Smith G
    Pediatr Nephrol; 1999 Jun; 13(5):465. PubMed ID: 10412872
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up.
    Lama G; Salsano ME; Pedulla' M; Grassia C; Ruocco G
    Pediatr Nephrol; 1997 Dec; 11(6):714-8. PubMed ID: 9438650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
    Savin M; Petronić V
    Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure induced by an angiotensin II receptor antagonist in a 14-year-old boy with reflux nephropathy.
    Fujinaga S; Kaneko K; Ohtomo Y; Yamashiro Y
    Pediatr Nephrol; 2006 Apr; 21(4):601-2. PubMed ID: 16534606
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reflux nephropathy in vesico-ureteral reflux (VUR)].
    Shigematsu H
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):275-7. PubMed ID: 9277740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflux nephropathy caused by vesico-ureteral reflux].
    Thomsen HS
    Ugeskr Laeger; 1983 Oct; 145(43):3334-8. PubMed ID: 6659102
    [No Abstract]   [Full Text] [Related]  

  • 8. Vesico ureteric reflux and reflux nephropathy.
    Visweswaran RK; Bhat VN
    J Assoc Physicians India; 1988 Sep; 36(9):555-9. PubMed ID: 3249011
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Yang et al. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Mandal A
    Clin Nephrol; 2006 Mar; 65(3):227; author reply 227-8. PubMed ID: 16550756
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACE-inhibitors indicated even in non-diabetic nephropathy].
    Internist (Berl); 1996 Oct; 37(10 Suppl Ace-hemmer):1-8. PubMed ID: 9402421
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL; Kalus JS; Coleman CI; Manierski C; Yee J
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux nephropathy: 1987.
    Bailey RR
    N Z Med J; 1987 Jul; 100(827):409-11. PubMed ID: 3330587
    [No Abstract]   [Full Text] [Related]  

  • 13. The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy.
    Zaltzman JS; Nash M; Chiu R; Prasad R
    Nephrol Dial Transplant; 2004 Apr; 19(4):940-4. PubMed ID: 15031353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease: tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    McCullough PA
    Circulation; 2006 Jul; 114(1):6-7. PubMed ID: 16818827
    [No Abstract]   [Full Text] [Related]  

  • 15. Fabry nephropathy and the case for adjunctive renal therapy.
    Wanner C; Breunig F
    J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current indications for the treatment with angiotensin-converting enzyme inhibitors].
    Orte Martínez LM
    Rev Clin Esp; 1996 Jun; 196(6):345-6. PubMed ID: 8767066
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases.
    Lefebvre HP; Toutain PL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):265-81. PubMed ID: 15500563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.
    Pennesi M; Torre G
    Pediatr Nephrol; 2000 May; 14(5):438. PubMed ID: 10805476
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reflux nephropathy and arterial hypertension].
    Jaboureck O; Pretorian E; Dujardin JJ; Joly P; Leroy F; Mounier-Vehier C
    Ann Cardiol Angeiol (Paris); 2003 Nov; 52(5):313-6. PubMed ID: 14714346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.